Windsor Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,540
Closed -$325K 234
2021
Q4
$325K Sell
2,540
-12
-0.5% -$1.72K 0.06% 183
2021
Q3
$351K Buy
2,552
+52
+2% +$6.56K 0.07% 170
2021
Q2
$267K Buy
+2,500
New +$240K 0.06% 187

Other funds holding DXCM

Windsor Wealth Management's DXCM Position: Q1 2022 in Review

Windsor Wealth Management sold out of DexCom (DXCM) in Q1 2022, closing a stake of 2,540 shares — an estimated $325K sold.

Windsor Wealth Management first reported a position in DXCM in Q2 2021 and held it in 3 quarters. The position peaked at $351K in Q3 2021. 861 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • Windsor Wealth Management reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
  • Windsor Wealth Management sold 2,540 DexCom shares in Q1 2022, an estimated $325K.
  • Windsor Wealth Management first reported a position in DexCom in Q2 2021 and held it in 3 quarters.
  • Windsor Wealth Management's DexCom position peaked at $351K in Q3 2021.
  • 861 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Windsor Wealth Management's 13F filing for Q1 2022, filed 4 May 2022.